{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:07:11Z","timestamp":1793848031971,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guizhou Provincial Science and Technology Foundation","award":["Qiankehe Basic-ZK [2021] General 383"],"award-info":[{"award-number":["Qiankehe Basic-ZK [2021] General 383"]}]},{"DOI":"10.13039\/100017957","name":"Guizhou Provincial Health Commission","doi-asserted-by":"crossref","award":["gzwkj2023-034"],"award-info":[{"award-number":["gzwkj2023-034"]}],"id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14878-3","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:49:58Z","timestamp":1762339798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role and mechanism of circ_001024 endogenous competition for miR-145-3p targeting to regulate GLUT5 in RCC"],"prefix":"10.1186","volume":"25","author":[{"given":"Lanlan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"12","key":"14878_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY. Renal cell carcinoma: a review. JAMA. 2024;332(12):1001\u201310.","journal-title":"JAMA"},{"issue":"1","key":"14878_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"14878_CR3","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jgg.2022.05.004","volume":"49","author":"P Zhang","year":"2022","unstructured":"Zhang P, Dai M. CircRNA: a rising star in plant biology. J Genet Genomics. 2022;49(12):1081\u201392.","journal-title":"J Genet Genomics"},{"issue":"4","key":"14878_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/EBC20200032","volume":"65","author":"H Yan","year":"2021","unstructured":"Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65(4):625\u201339.","journal-title":"Essays Biochem"},{"issue":"12","key":"14878_CR5","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11864-023-01161-5","volume":"24","author":"YW Chen","year":"2023","unstructured":"Chen YW, Wang L, Panian J, Dhanji S, Derweesh I, Rose B, et al. Treatment landscape of renal cell carcinoma. Curr Treat Options Oncol. 2023;24(12):1889\u2013916.","journal-title":"Curr Treat Options Oncol"},{"issue":"16","key":"14878_CR6","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100836","volume":"38","author":"IL Patop","year":"2019","unstructured":"Patop IL, W\u00fcst S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019;38(16): e100836.","journal-title":"EMBO J"},{"issue":"11","key":"14878_CR7","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1158\/1078-0432.CCR-22-3836","volume":"29","author":"N Ding","year":"2023","unstructured":"Ding N, You AB, Yang H, Hu GS, Lai CP, Liu W, et al. A tumor-suppressive molecular axis EP300\/circRERE\/miR-6837-3p\/MAVS activates type I IFN pathway and antitumor immunity to suppress colorectal cancer. Clin Cancer Res. 2023;29(11):2095\u2013109.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"14878_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12943-022-01606-9","volume":"21","author":"X Zang","year":"2022","unstructured":"Zang X, Jiang J, Gu J, Chen Y, Wang M, Zhang Y. al.Circular RNA EIF4G3 suppresses gastric cancer progression through Inhibition of \u03b2-catenin by promoting \u03b4-catenin ubiquitin degradation and upregulating SIK1. Mol Cancer. 2022;21(1):141.","journal-title":"Mol Cancer"},{"issue":"3","key":"14878_CR9","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1080\/21655979.2022.2037870","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Xu Y, Zheng Q. CircRNA_0000285 knockdown suppresses viability and promotes apoptosis of cervical cancer cells by sponging microrna-654-3p. Bioengineered. 2022;13(3):5251\u201361.","journal-title":"Bioengineered"},{"issue":"2","key":"14878_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41419-020-2336-0","volume":"11","author":"L Cao","year":"2020","unstructured":"Cao L, Wang M, Dong Y, Xu B, Chen J, Ding Y, Circular, et al. RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a\/HIF-1\u03b1\/HK2. Cell Death Dis. 2020;11(2):145.","journal-title":"Cell Death Dis"},{"issue":"1","key":"14878_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01912-w","volume":"23","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zeng X, Zhu Y, Leng M, Zhang Z, Wang Q, et al. CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p\/CYP1B1 axis. Mol Cancer. 2024;23(1): 4.","journal-title":"Mol Cancer"},{"issue":"5","key":"14878_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000522190","volume":"47","author":"X Shi","year":"2022","unstructured":"Shi X, Song S, Gao Y, Cui Z, Wang W, Liu M. Circ_0037866 contributes to the tumorigenesis of renal cell carcinoma by sequestering miR-384 to elevate chromobox 5 expression. Kidney Blood Press Res. 2022;47(5):329\u201340.","journal-title":"Kidney Blood Press Res"},{"issue":"12","key":"14878_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05488-z","volume":"13","author":"B Zhao","year":"2022","unstructured":"Zhao B, Huang C, Pan J, Hu H, Liu X, Zhang K, Zhou F, Shi X, Wu J, Yu B, Chen X, Zhang W. CircPLIN2 promotes clear cell renal cell carcinoma progression by binding IGF2BP proteins and miR-199a-3p. Cell Death Dis. 2022;13(12): 1030.","journal-title":"Cell Death Dis"},{"issue":"14","key":"14878_CR14","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, et al. miRNA-based biomarkers, therapies, and resistance in cancer. Int J Biol Sci. 2020;16(14):2628\u201347.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"14878_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","volume":"39","author":"K Bi","year":"2021","unstructured":"Bi K, He MX, Bakouny Z, Kanodia A, Napolitano S, Wu J, et al. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell. 2021;39(5):649\u201361.","journal-title":"Cancer Cell"},{"issue":"2","key":"14878_CR16","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/bib\/bbaa001","volume":"22","author":"L Chen","year":"2021","unstructured":"Chen L, Wang C, Sun H, Wang J, Liang Y, Wang Y, et al. The bioinformatics toolbox for circRNA discovery and analysis. Brief Bioinform. 2021;22(2):1706\u201328.","journal-title":"Brief Bioinform"},{"issue":"1","key":"14878_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-023-01726-w","volume":"22","author":"Y Liang","year":"2023","unstructured":"Liang Y, Cen J, Huang Y, Fang Y, Wang Y, Shu G, et al. CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic Silencing of slug. Mol Cancer. 2023;22(1):14.","journal-title":"Mol Cancer"},{"issue":"1","key":"14878_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01314-w","volume":"20","author":"J Cen","year":"2021","unstructured":"Cen J, Liang Y, Huang Y, Pan Y, Shu G, Zheng Z, et al. Circular RNA circsdhc serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3\/E2F1 axis. Mol Cancer. 2021;20(1): 19.","journal-title":"Mol Cancer"},{"issue":"2","key":"14878_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04623-0","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu X, Zhou J, Zhao L, Yang Z, Yang C, Chen Y, et al. CircCYP24A1 hampered malignant phenotype of renal cancer carcinoma through modulating CMTM-4 expression via sponging miR-421. Cell Death Dis. 2022;13(2): 190.","journal-title":"Cell Death Dis"},{"issue":"2","key":"14878_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3892\/ijo.2023.5477","volume":"62","author":"D Pan","year":"2023","unstructured":"Pan D, Jia Z, Li W, Dou Z. The targeting of MTDH by miR-145-5p or miR-145-3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells. Int J Oncol. 2023;62(2):29.","journal-title":"Int J Oncol"},{"issue":"9","key":"14878_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00424-020-02411-3","volume":"472","author":"GD Holman","year":"2020","unstructured":"Holman GD. Structure, function and regulation of mammalian glucose transporters of the SLC2 family. Pflugers Arch. 2020;472(9):1155\u201375.","journal-title":"Pflugers Arch"},{"issue":"9","key":"14878_CR22","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00424-020-02439-5","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H. Glucose transporters in the small intestine in health and disease. Pflugers Arch. 2020;472(9):1207\u201348.","journal-title":"Pflugers Arch"},{"issue":"7573","key":"14878_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature14909","volume":"526","author":"N Nomura","year":"2015","unstructured":"Nomura N, Verdon G, Kang HJ, Shimamura T, Nomura Y, Sonoda Y, et al. Structure and mechanism of the mammalian fructose transporter GLUT5. Nature. 2015;526(7573):397\u2013401.","journal-title":"Nature"},{"key":"14878_CR24","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.2147\/OTT.S205522","volume":"12","author":"C Jin","year":"2019","unstructured":"Jin C, Gong X, Shang Y. Glut5 increases fructose utilization in ovarian cancer. Onco Targets Ther. 2019;12:5425\u201336.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"14878_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131596","volume":"5","author":"WL Chen","year":"2020","unstructured":"Chen WL, Jin X, Wang M, Liu D, Luo Q, Tian H, et al. Glut5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK\/mTORC1 signaling. JCI Insight. 2020;5(3): e131596.","journal-title":"JCI Insight"},{"issue":"3","key":"14878_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s43440-021-00281-9","volume":"73","author":"J W\u0142odarczyk","year":"2021","unstructured":"W\u0142odarczyk J, W\u0142odarczyk M, Zieli\u0144ska M, J\u0119drzejczak B, Dziki \u0141, Fichna J. Blockade of fructose transporter protein GLUT5 inhibits proliferation of colon cancer cells: proof of concept for a new class of anti-tumor therapeutics. Pharmacol Rep. 2021;73(3):939\u201345.","journal-title":"Pharmacol Rep"},{"key":"14878_CR27","doi-asserted-by":"publisher","first-page":"24240","DOI":"10.1038\/srep24240","volume":"6","author":"AM George Thompson","year":"2016","unstructured":"George Thompson AM, Ursu O, Babkin P, Iancu CV, Whang A, Oprea TI, et al. Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation. Sci Rep. 2016;6:24240.","journal-title":"Sci Rep"},{"issue":"1","key":"14878_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06262-4","volume":"7","author":"J Tripp","year":"2017","unstructured":"Tripp J, Essl C, Iancu CV, Boles E, Choe JY, Oreb M. Establishing a yeast-based screening system for discovery of human GLUT5 inhibitors and activators. Sci Rep. 2017;7(1): 6197.","journal-title":"Sci Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14878-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14878-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14878-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:49:59Z","timestamp":1762339799000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14878-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14878"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14878-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Affiliated Hospital of Zunyi Medical College (Approval No. KLL-2020-096), adhering to the Declaration of Helsinki and informed consent was obtained from all participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1713"}}